S100A11 (calgizzarin) is released by circulating mononuclear cells and its elevated plasma levels distinguish systemic lupus erythematosus patients from healthy individuals
Clin Exp Rheumatol
.
2019 Mar-Apr;37(2):338-339.
Epub 2019 Feb 4.
Authors
Lucie Andres Cerezo
1
,
Barbora Šumová
2
,
Hana Hulejová
1
,
Hana Štorkánová
2
,
Lenka Szczuková
3
,
Michal Tomčík
2
,
Radim Bečvář
2
,
Karel Pavelka
2
,
Jiří Vencovský
2
,
Jakub Závada
2
,
Ladislav Šenolt
4
Affiliations
1
Institute of Rheumatology, Prague, Czech Republic.
2
Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
3
Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
4
Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic. senolt@revma.cz.
PMID:
30719969
No abstract available
Publication types
Letter
MeSH terms
Humans
Lupus Erythematosus, Systemic* / metabolism
S100 Proteins* / metabolism
Substances
S100 Proteins
S100A11 protein, human